Invesco Ltd. Iveric Bio, Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$26.24 - $39.63 $36 Million - $54.4 Million
-1,371,528 Reduced 67.61%
657,083 $25.8 Million
Q1 2023

May 12, 2023
BUY
$18.67 - $24.56 $11.5 Million - $15.1 Million
616,275 Added 43.64%
2,028,611 $49.4 Million
Q4 2022

Feb 13, 2023
BUY
$17.24 - $23.95 $17.4 Million - $24.2 Million
1,008,383 Added 249.63%
1,412,336 $30.2 Million
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $3.23 Million - $6.39 Million
343,778 Added 571.3%
403,953 $7.25 Million
Q2 2022

Aug 15, 2022
SELL
$9.12 - $18.9 $5.23 Million - $10.8 Million
-573,332 Reduced 90.5%
60,175 $579,000
Q1 2022

May 16, 2022
BUY
$12.15 - $16.83 $7.18 Million - $9.94 Million
590,773 Added 1382.44%
633,507 $10.7 Million
Q4 2021

Feb 14, 2022
SELL
$13.83 - $18.78 $28.7 Million - $38.9 Million
-2,072,768 Reduced 97.98%
42,734 $715,000
Q3 2021

Nov 15, 2021
BUY
$7.07 - $17.5 $14.7 Million - $36.4 Million
2,082,326 Added 6276.6%
2,115,502 $34.4 Million
Q2 2021

Aug 17, 2021
BUY
$5.69 - $7.17 $67,676 - $85,279
11,894 Added 55.89%
33,176 $209,000
Q1 2021

May 17, 2021
BUY
$5.08 - $6.89 $11,877 - $16,108
2,338 Added 12.34%
21,282 $132,000
Q4 2020

Feb 16, 2021
SELL
$5.65 - $7.66 $6.08 Million - $8.24 Million
-1,076,136 Reduced 98.27%
18,944 $131,000
Q3 2020

Nov 16, 2020
BUY
$4.01 - $6.29 $3.38 Million - $5.31 Million
843,570 Added 335.4%
1,095,080 $6.18 Million
Q2 2020

Aug 14, 2020
SELL
$3.06 - $6.6 $1.94 Million - $4.18 Million
-632,645 Reduced 71.55%
251,510 $1.28 Million
Q1 2020

May 15, 2020
SELL
$2.83 - $8.44 $252,348 - $752,586
-89,169 Reduced 9.16%
884,155 $3.04 Million
Q4 2019

Feb 14, 2020
BUY
$0.93 - $8.58 $905,191 - $8.35 Million
973,324 New
973,324 $8.35 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email